<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05005806</url>
  </required_header>
  <id_info>
    <org_study_id>Fish oil in Sjogren Syndrome</org_study_id>
    <nct_id>NCT05005806</nct_id>
  </id_info>
  <brief_title>Fish Oil (Omega 3 ) in Sjogren's Syndrome</brief_title>
  <official_title>Randomised Double-blind Placebo-controlled Clinical Trial of Fish Oil (Omega 3 ) in Sjögren's Syndrome Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hawler Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hawler Medical University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sjögren's syndrome (pSS) is an autoimmune disorder affecting mainly the exocrine glands.this&#xD;
      lead to dryness of the main mucosal surface ,such as the mouth ,eye,skin nose,pharynx,larynx&#xD;
      and vagina . The history of the disease is characterized by a slowly progression of sicca&#xD;
      symptoms and fatigue; however, a subset of patients would experience extra glandular&#xD;
      activity. Lipid mediators derived from polyunsaturated fatty acids, related to inflammation&#xD;
      and immune response regulation. In this sense, the polyunsaturated fatty acids omega-3 (ω-3&#xD;
      FA) have been associated with several illnesses such as cancer, cardiovascular disease and&#xD;
      autoimmune diseases and their balance at the cellular membranes can result in an&#xD;
      anti-inflammatory .&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      this is a randomized double -blind placebo -controlled clinical trial .the participants will&#xD;
      be randomize into two groups .Group 1 receive dietary omega-3 supplementation (omega-3 group)&#xD;
      whereas Group 2(placebo group) receive a placebo . The two types are similar to each other in&#xD;
      the form of soft gel ,both are given two times daily for two months with follow-up of&#xD;
      patients whom they full fill the inclusion criteria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2021</start_date>
  <completion_date type="Anticipated">February 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>100 participants will asses for eligibility and underwent randomized double blind placebo controlled clinical trial .in whom they meet inclusion criteria with informed consent from participants and will be held at out patient clinic of Rheumatology department at Erbil- Iraq.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dry eye symptoms</measure>
    <time_frame>up to two months</time_frame>
    <description>subjective symptoms of dry eye which involve 6 symptoms( burning sensation, itching, foreign body sensation , Dryness, mucous discharge, photophobia) when absent(0) , sometime present (1) , frequently present (2), always present (3) ( score 0-6 mild, 6-12 moderate, 12-18 sever by visual analogue scale</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Dry mouth symptoms</measure>
    <time_frame>up to two months</time_frame>
    <description>measure dry mouth by inventory xerostomia score is included 11 questionnaire which score calculated by visual analogue scale from 1 to 5 ( never to very often ) have symptoms</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>schirmers tear test</measure>
    <time_frame>up to two months</time_frame>
    <description>patient will sitt in examining chair ,the test strip is bend with round wick and at indentation ( approximately 90 degree ) then patient instruct to look up and draw eye gently downward ,then round bend end of sterile strip hook over eyelid border at junction of middle and outer one third of the lower eyelid margin.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sialometry test</measure>
    <time_frame>up to two months</time_frame>
    <description>measuring of salivary flow ,unstimulated whole saliva is collect when mouth rinse with distill water then the patient tow his head and try not to move during the test, a plastic disposable pipette drew the accumulated saliva in the floor of the mouth,for a period of five minute,the volume will record ,flow express as ml/min.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Sjogren's Syndrome</condition>
  <arm_group>
    <arm_group_label>Omega 3 soft gel</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>participants in this group (1)omega 3 fatty acid soft gel 1000 mg will be given to participants twice daily for two months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>placebo group ,placebo soft gel designed same as omega 3 contain Vitamin A 1000 mg twice daily for two months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Omega 3 fatty acid</intervention_name>
    <description>omega 3 fatty acid soft gel</description>
    <arm_group_label>Omega 3 soft gel</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>placebo soft gel</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age≥ 18 and ≤ 70 years old .&#xD;
&#xD;
          -  Able to provide inform consent&#xD;
&#xD;
          -  Patients diagnosed as syndrome according to 2016 ACR(American college of&#xD;
             Rheumatology)/ EULAR(European league Against Rheumatism classification criteria for&#xD;
             Sjögren's syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  any preexisting ocular disease or on eye drops lubricants.&#xD;
&#xD;
          -  patients on (Beta blockers, Diuretics , anticholinergic, α 1antagonist and α 2 agonist&#xD;
             ,anticoagulant, antidepressant, antihistamine ,pilocarpine, cevimeline ) .&#xD;
&#xD;
          -  past history of diabetes, psychiatric disorder.&#xD;
&#xD;
          -  pregnancy, lactating mother&#xD;
&#xD;
          -  malignancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ziad SH AL Rawi, F R C P London</last_name>
    <role>Study Director</role>
    <affiliation>Professor of Rheumatolgy,Baghdad University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aryan MF Jalal, M.B.CH.B</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rheumatology,Hawler medical uiversity,Kurdistan Board for medical specialities</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ibtihal HH Faraj, M-B.CH.B</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rheumatology,Hawler medical university</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Aryan MF Jalal, M.B.CH.B</last_name>
    <phone>009647504880817</phone>
    <email>aryan.jalal87@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ibtihal HH Faraj, M.B.CH.B</last_name>
    <phone>009647507584463</phone>
    <email>Ibtihal.hikmet@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Reumatology out patient clinic,</name>
      <address>
        <city>Erbil</city>
        <zip>44001</zip>
        <country>Iraq</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Iraq</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>August 5, 2021</study_first_submitted>
  <study_first_submitted_qc>August 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 16, 2021</study_first_posted>
  <last_update_submitted>August 12, 2021</last_update_submitted>
  <last_update_submitted_qc>August 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hawler Medical University</investigator_affiliation>
    <investigator_full_name>Aryan Mohamadfatih Jalal</investigator_full_name>
    <investigator_title>principal investigator</investigator_title>
  </responsible_party>
  <keyword>Sjogren's syndrome</keyword>
  <keyword>Omega 3 fatty acid</keyword>
  <keyword>dry eye</keyword>
  <keyword>dry mouth</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sjogren's Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

